Pharmacovigilance evaluation of the relationship between impaired glucose metabolism and BCR‐ABL inhibitor use by using an adverse drug event reporting database

Breakpoint cluster region‐Abelson murine leukemia (BCR‐ABL) inhibitors markedly improve the prognosis of chronic myeloid leukemia. However, high treatment adherence is necessary for successful treatment with BCR‐ABL inhibitors. Therefore, an adequate understanding of the adverse event profiles of BC...

Descripción completa

Detalles Bibliográficos
Autores principales: Okada, Naoto, Niimura, Takahiro, Zamami, Yoshito, Hamano, Hirofumi, Ishida, Shunsuke, Goda, Mitsuhiro, Takechi, Kenshi, Chuma, Masayuki, Imanishi, Masaki, Ishizawa, Keisuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Clinical Cancer Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346261/
https://www.ncbi.nlm.nih.gov/pubmed/30561126
http://dx.doi.org/10.1002/cam4.1920

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6346261/
https://www.ncbi.nlm.nih.gov/pubmed/30561126
http://dx.doi.org/10.1002/cam4.1920

Ejemplares similares